Bibliography
- FULLER PJ, YOUNG MJ: Mechanisms of mineralocorticoid action. Hypertension (2005) 46:1227-1235
- FUNDER JW: Is aldosterone bad for the heart? Trends Endocrinol. Metab. (2004) 15:139-42.
- JUURLINK DN, MAMDANI MM, LEE DS et al.: Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N. Engl. J. Med. (2004) 351:543-551
- LEVY DG, ROCHA R, FUNDER JW: Distinguishing the antihypertensive and electrolyte effects of eplerenone. J. Clin. Endocrinol. Metab. (2004) 89:2736-2740.
- BOHL CE, MILLER DD, CHEN J, BELL CE, DALTON JT: Structural basis for accommodation of nonsteroidal ligands in the androgen receptor. J. Biol. Chem. (2005) 280:37747-37754.
- MINER JN, HONG MH, NEGRO-VILAR A: New and improved glucocorticoid receptor ligands. Expert Opin. Investig. Drugs (2005) 14:1527-1545.
- GRONEMEYER H, GUSTAFSSON JÅ, LAUDET V: Principles for modulation of the nuclear receptor superfamily. Nat. Rev. (2004) 3:950-964.
- KAUPP B, JAKOB C, FARNEGARDH M et al.: The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain. J. Biol. Chem. (2003) 278:22748-22754.
- FAGART J, HUYET J, PINON GM et al.: Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat. Struct. Mol. Biol. (2005) 12:554-555.
- LI Y, SUINO K, DAUGHERTY J, XU HE: Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol. Cell (2005) 19:367-380.
- BLEDSOE RK, MADAUSS KP, HOLT JA et al.: A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J. Biol. Chem. (2005) 280:31283-31293.